ImaginAb, Inc. U.S.
Latest round
- Series B
Last raised
- May 2014
Total raised
- $23M
Investors
- 6
About ImaginAb, Inc. U.S.
ImaginAb, Inc.S.Founded in 2007 in Inglewood, US, ImaginAb, Inc. focuses on advanced imaging solutions for oncology, specifically through its flagship product.ImaginAb’s core product is its advanced imaging agent, 89Zr crefmirlimab berdoxam, branded as CD8 ImmunoPET™, which enhances visualization of CD8 T-cells in oncology.ImaginAb generates revenue through partnerships and collaborations with healthcare providers and pharmaceutical companies that utilize its CD8 ImmunoPET™ technology. The revenue stems from licensing agreements and collaborative research contracts, supporting clinical applications in oncology.In January 2025, Telix Pharmaceuticals Limited is set to acquire ImaginAb, Inc. to enhance its CD8 ImmunoPET technology currently in Phase 2 clinical trials. This acquisition aims to accelerate the development of its prostate cancer imaging agent and strengthen its market position.
Who invested in ImaginAb, Inc. U.S.
6 investors across 2 rounds
See all investors in ImaginAb, Inc. U.S.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImaginAb, Inc. U.S.
Who invested in ImaginAb, Inc. U.S.?
ImaginAb, Inc. U.S. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImaginAb, Inc. U.S. raised?
ImaginAb, Inc. U.S. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ImaginAb, Inc. U.S. last raise money?
ImaginAb, Inc. U.S.'s most recent round on record is a Series B, in May 2014.
What does ImaginAb, Inc. U.S. do?
ImaginAb, Inc. U.S. is a biotechnology company.
Where is ImaginAb, Inc. U.S. headquartered?
ImaginAb, Inc. U.S. is headquartered in Inglewood, US.
Which VCs invest in companies like ImaginAb, Inc. U.S.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ImaginAb, Inc. U.S.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ImaginAb, Inc. U.S.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.